-
On June 15, the fifth round of interpretation of the new standard of drinking water GB5749 will meet again!
Time of Update: 2022-08-15
Therefore, it is necessary to 2 -Methyl isocamphenol, geosmin and other substances are detected Among them, there are many problems of exceeding the standard of organic matter and microorganism detection, and this new standard focuses on chroma, turbidity, odor and taste, which are closely related to the direct impact of algae outbreaks on water quality in recent years.
-
Recently, domestic pharmaceutical companies ADC drugs have performed well in overseas markets!
Time of Update: 2022-08-15
In addition, on July 26, Kelun Pharmaceuticals just announced that it has reached a research and development cooperation and license agreement with Merck & Co. for ADC drugs (Project B) for the treatment of solid tumors, involving a total amount of over 900 million US dollars .
-
The semi-annual reports of biopharmaceutical companies have been released one after another. Innovent, Henlius, Betta, etc. have entered the CDMO market strongly! Is it better to "sell water" to be innovative drugs?
Time of Update: 2022-08-15
In fact, in addition to the old CDMO players, Biotech innovative pharmaceutical companies as Party A have recently entered the CDMO Party B market, which has attracted industry attention: In May of this year, Innovent Bio launched Sherpa Bio. In addition to the production and supply of Innovent Bio’s current biopharmaceutical pipeline, Sherpa Bio will also undertake CDMO business as a means to improve the company’s efficiency .
-
The tide of cooperation between pharmaceutical companies continues, and this field is attracting more and more companies to deploy
Time of Update: 2022-08-15
Yunnan Baiyao will carry out extensive exchanges and cooperation with Huawei Technologies in the field of artificial intelligence drug research and development, explore the mechanism of joint scientific research and innovation, and expand the breadth and depth of cooperation between the two parties, including but not limited to large and small molecule design, related diseases, database development, etc.
-
Reducing prices, relaxing frequency, and cracking down on chaos, concept stocks have fled funds!
Time of Update: 2022-08-15
On May 23, at the press conference of the Joint Prevention and Control Mechanism of the State Council, Guo Yanhong, the supervisory commissioner of the Medical Administration and Hospital Administration Bureau of the National Health and Health Commission, said that normalized nucleic acid testing should be determined according to the needs of local epidemic prevention and control, not one size fits all.
-
PHEXCOM successfully completed the quality audit of Kerry company
Time of Update: 2022-08-15
On May 3, PHEXCOM conducted an audit on the pharmaceutical excipient company-Kerry's US factory .
On May 3, PHEXCOM conducted an audit on the pharmaceutical excipient company-Kerry's US factory .
On May 3, PHEXCOM conducted an audit on the pharmaceutical excipient company-Kerry's US factory .
-
Popular science: How effective is the existing new crown vaccine against the Omicron strain
Time of Update: 2022-08-15
Reinforcing needles significantly improve protection In the weekly epidemic report released by the World Health Organization on the 11th, the conclusions of 23 studies evaluating the protective efficacy of the existing new crown vaccines against the infection of the Omicron strain were summarized .
-
$90 million development milestone payment!
Time of Update: 2022-08-15
On August 5, Kelun Pharmaceutical announced that its holding subsidiary Kelun Botai will exclusively license its biological macromolecular tumor project A (SKB264) with independent intellectual property rights to MSD in May 2022 to conduct ( China includes mainland China, Hong Kong, Macau and Taiwan) regional research, development, manufacturing and commercialization .
-
"Chinese Pharmacopoeia" draft standards for pharmaceutical packaging materials are solicited for comments, the first round ends on September 1
Time of Update: 2022-08-15
Contact number: 010-67079620, 67079566 Attachment: List of draft standards for pharmaceutical packaging materials that have been publicly solicited for comments For details, please click [ read the original text ] to view On July 18, the official website of the State Pharmacopoeia Committee issued a notice to solicit opinions on the first batch of 46 draft standards .
-
Notice of Postponement of "Packaging World (Shanghai) Expo"
Time of Update: 2022-08-15
Dear exhibitors, partners, audience friends, and media friends: In view of the current epidemic prevention and control policies in Shanghai and many places across the country, and at the same time to
-
In the second quarter, the pharmaceutical and biological sector received more than 100 public funds for investigation
Time of Update: 2022-08-15
2%; the net profit attributable to the parent was 120 million yuan, a year-on-year increase of 19.
2%; the net profit attributable to the parent was 120 million yuan, a year-on-year increase of 19.
-
The seventh batch of national procurement is connected to MAH, and the threshold for domestic agents is raised, which is beneficial to enterprises with their own production lines
Time of Update: 2022-08-15
0 1 The threshold for domestic agents is raised In terms of application qualifications, the seventh batch of centralized procurement requires domestic drug manufacturers, drug marketing authorization holders, and domestic agents of overseas drug marketing authorization holders that provide drugs and accompanying services, in terms of quality standards, production capacity, supply stability, Those who meet the requirements of this centralized procurement in terms of corporate credit and other aspects can participate .
-
12 models were approved in the first half of the year!
Time of Update: 2022-08-15
【Pharmaceutical Industry News】 In recent years, with the strong support of the state, the development of children's medicine has shown a steady trend . According to statistics, among the new drugs ap
-
Another License out!
Time of Update: 2022-08-15
Huadong Medicine's liraglutide is expected to be approved within the year, and the research and development progress of hypoglycemic and weight loss indications is the fastest in China The joint product liraglutide injection is a human glucagon-like peptide-1 (GLP-1) receptor agonist.
-
Such a hot topic of "green and good technology in chemical industry parks", how can you miss the online roadshow on August 5!
Time of Update: 2022-08-15
[Pharmaceutical Network Conference Forum] The chemical industry park was born out of the large-scale and intensive development requirements of the chemical industry. It is the main gathering area of
-
Listed pharmaceutical companies get together to become LPs become the norm!
Time of Update: 2022-08-15
, Ltd. and another company with 50% of their respective contributions, and manages a fund, namely the Liaoning Sunshine Medical Industry Investment Fund Partnership (Limited Partnership) established in 2017 .
-
【Know·Chen】Dongchen Pharmaceutical is not just an MCC manufacturer!
Time of Update: 2022-08-15
Some instruments and equipment of Dongchen Pharmaceutical Dongchen Pharmaceutical Qualification and Honor December 2021: Microcrystalline cellulose was activated under CDE registration number F20180000805 for use in pharmaceutical production .
-
Notice on the adjustment of the exhibition period of the 88th API China and the 26th CHINA-PHARM
Time of Update: 2022-08-15
Dear exhibitors, visitors and friends in the industry: In view of the recent spread of the epidemic in many places in China, the prevention and control situation is still severe and complicated. A pr
-
The highest drop is 97%!
Time of Update: 2022-08-15
, the quotation strategy is becoming more and more mature The average price of the drugs to be selected is reduced by 48%; it is the same as the special centralized procurement of insulin, but the decline is moderated compared with the first five batches of centralized procurement.
-
Shanghai Internet diagnosis and treatment realizes cross-hospital follow-up consultation and dispensing to improve medical accessibility
Time of Update: 2022-08-15
. Zhao Dandan said that the health departments of all districts will further optimize the acceptance and approval process of "Internet hospitals" and "Internet diagnosis and treatment service methods", strengthen business guidance for medical institutions, and encourage qualified medical institutions to apply for Internet diagnosis and treatment services as much as possible .
